Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Boice

Showing results (151-160 of 216) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|July 11, 1991
Cancer risks in thyroid cancer patientsP Hall, L E Holm, G Lundell, et al.
Cancer Causes & Control : CCC|September 11, 1992
Leukemia, lymphoma, and multiple myeloma following selected medical conditionsM M Doody, M S Linet, A G Glass, et al.
Cancer Research|January 15, 1995
Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphomaJ H Olsen, G Schulgen, J D Boice, et al.
Epidemiology (Cambridge, Mass.)|March 1, 1996
Childhood exposure to magnetic fields: residential area measurements compared to personal dosimetryD R Friedman, E E Hatch, R Tarone, et al.
BMJ (Clinical Research Ed.)|March 11, 1998
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in SwedenO Nyrén, L Yin, S Josefsson, et al.
Lancet (London, England)|July 14, 1992
Leukaemia incidence after iodine-131 exposureP Hall, J D Boice, G Berg, et al.
International Journal of Cancer|April 11, 1992
Cancer mortality after iodine-131 therapy for hyperthyroidismP Hall, G Berg, G Bjelkengren, et al.
International Journal of Cancer|June 11, 1997
Breast implants and cancer risk in DenmarkS Friis, J K McLaughlin, L Mellemkjaer, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|December 2, 2020
Using personal monitoring data to derive organ doses for medical radiation workers in the Million Person Study-considerations regarding NCRP Commentary no. 30C Yoder, S Balter, J D Boice, et al.
The New England Journal of Medicine|November 3, 1983
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)J D Boice, M H Greene, J Y Killen, et al.
Pageof 22

Showing results (151-160 of 216) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|July 11, 1991
Cancer risks in thyroid cancer patientsP Hall, L E Holm, G Lundell, et al.
Cancer Causes & Control : CCC|September 11, 1992
Leukemia, lymphoma, and multiple myeloma following selected medical conditionsM M Doody, M S Linet, A G Glass, et al.
Cancer Research|January 15, 1995
Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphomaJ H Olsen, G Schulgen, J D Boice, et al.
Epidemiology (Cambridge, Mass.)|March 1, 1996
Childhood exposure to magnetic fields: residential area measurements compared to personal dosimetryD R Friedman, E E Hatch, R Tarone, et al.
BMJ (Clinical Research Ed.)|March 11, 1998
Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in SwedenO Nyrén, L Yin, S Josefsson, et al.
Lancet (London, England)|July 14, 1992
Leukaemia incidence after iodine-131 exposureP Hall, J D Boice, G Berg, et al.
International Journal of Cancer|April 11, 1992
Cancer mortality after iodine-131 therapy for hyperthyroidismP Hall, G Berg, G Bjelkengren, et al.
International Journal of Cancer|June 11, 1997
Breast implants and cancer risk in DenmarkS Friis, J K McLaughlin, L Mellemkjaer, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|December 2, 2020
Using personal monitoring data to derive organ doses for medical radiation workers in the Million Person Study-considerations regarding NCRP Commentary no. 30C Yoder, S Balter, J D Boice, et al.
The New England Journal of Medicine|November 3, 1983
Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU)J D Boice, M H Greene, J Y Killen, et al.
Pageof 22